First Clinical Evaluation of HEARO Robotic Cochlear Implantation Surgery in Austria
NCT ID: NCT04795986
Last Updated: 2021-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10 participants
OBSERVATIONAL
2021-09-17
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Performance of a Robot-assisted Minimally Invasive Direct Cochlear Access for Cochlear Implantation
NCT04610450
Innovations in Clinical Care of CE Approved Nucleus Cochlear Implant Recipients
NCT05270876
Implantation of the Cochlear™ Nucleus® Hybrid S Round Window (S-RW) in Adults
NCT02638883
Feasibility of the Mi2000 Totally Implantable Cochlear Implant in Severely to Profoundly Deaf Adults.
NCT04571333
Clinical Investigation of the Nucleus® CI532 Cochlear Implant
NCT02392403
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study is an observational study of the first implementation in clinical routine in Austria.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HEARO Procedure
robotic access to the middle and inner ear in cochlear implantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant women
* Facial recess size does not allow a minimum distance of 0.4mm from the planned trajectory to the facial nerve and 0.3mm to the chorda tympani
* Vulnerable or mentally retarded candidates
* Invalid or withdrawn informed consent
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MED-EL Elektromedizinische Geräte GesmbH
INDUSTRY
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christoph Arnoldner
Assoc.-Prof. Priv.-Doz. Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HNO Klinik am AKH Wien
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HEARO-AT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.